word,tfidf
adverse,0.33784895676724724
investigator,0.33762466571602634
event,0.30930920471156653
sponsor,0.23228382487813928
report,0.22537094054189996
participant,0.2017317987187539
severe,0.19823557508945785
pregnancy,0.1961969831844471
department,0.17370306154546591
documents,0.1462104906533778
follow,0.13035724587594702
reports,0.12871521826750354
data,0.12650052262517933
safety,0.11724438682333696
email,0.11295820224314237
initial,0.09019739077328902
reason,0.08747636192937133
subject,0.08116807820282987
information,0.07944849896581385
hôpitaux,0.07872872573643419
assistance,0.07872872573643419
paris,0.07771411742824136
week,0.07685062723459424
possible,0.07661928893644981
shortening,0.074979738796604
participation,0.07248041417005052
sent,0.07248041417005052
consent,0.07166968607271147
fraction,0.06683638357342686
publique,0.06207132268269352
state,0.06026231305800783
french,0.059161729431942256
file,0.05873412872400646
assessment,0.057850848761514945
complete,0.05707950411136141
additional,0.05476547016090081
methodology,0.05358273696149062
participants,0.05334254293043974
hospital,0.0526729018124747
monitored,0.052592564123352295
medical,0.05245143621044022
signed,0.051496885704115786
protection,0.051402814096605576
following,0.05013740225997962
reference,0.04749196065059194
written,0.04711417202716976
et,0.047052023659365484
resolved,0.046341826561289184
informatique,0.0448936444812489
inclusion,0.04473798970890489
centers,0.043738180964685666
84,0.04344546240120861
lost,0.04248851865140893
center,0.04170416992743471
reasons,0.04170416992743471
disease,0.04088126645813722
outcome,0.04088126645813722
kilograms,0.040109921807983694
woman,0.039989194024855464
criteria,0.03972054890776781
amended,0.03910091616108775
collected,0.03885705871412068
emergency,0.03873953171157873
personal,0.03873953171157873
month,0.03799356852047355
analysis,0.037795887857523094
99,0.03765273408104746
soon,0.03765273408104746
collecting,0.03765273408104746
pregnant,0.037489869398302
reaction,0.037253066254041206
provide,0.03685484784284928
igg,0.03624020708502526
44,0.03624020708502526
termination,0.03624020708502526
requests,0.036204552001007174
schedule,0.036157387834804704
reporting,0.036157387834804704
transplant,0.035481853907062495
relating,0.034990544771748525
centres,0.03475636992096689
initials,0.03475636992096689
procedure,0.03393916460675543
arm,0.03393916460675543
cells,0.03393916460675543
source,0.03367611755223793
visit,0.03367611755223793
monitor,0.0333081878409266
contacted,0.0333081878409266
acronym,0.0333081878409266
recruitment,0.0333081878409266
discontinuation,0.03297539017518093
completed,0.03194913716494367
dr,0.031860005760886316
carry,0.031860005760886316
innovation,0.031860005760886316
sponsors,0.031860005760886316
product,0.03103566134134676
milligrams,0.030853786006141304
cell,0.030853786006141304
test,0.030853786006141304
terminated,0.030411823680846026
useful,0.029991895518641593
001,0.029991895518641593
cases,0.029583317319385665
use,0.029358666584002293
exposure,0.029358666584002293
national,0.02909593250751259
item,0.028963641600805744
list,0.028742233205364863
date,0.028539752055680705
withdrawal,0.028495176390355165
antigen,0.028495176390355165
centre,0.028495176390355165
acceptable,0.02848763890014916
human,0.027768407405527173
considered,0.027768407405527173
tc,0.027515459520765454
permanently,0.02749257089208813
ap,0.02749257089208813
tests,0.027391960480912653
left,0.027156203673678415
33,0.026768196003060914
previous,0.026768196003060914
recherche,0.026296282061676148
hp,0.026242908578811397
level,0.02622571810522011
explicit,0.026067277440725168
délégation,0.026067277440725168
sfgm,0.026067277440725168
evaluation,0.025904705809413786
laboratory,0.025904705809413786
events,0.025454373455066574
care,0.025454373455066574
anti,0.025454373455066574
addition,0.02521647483984424
section,0.02521647483984424
visits,0.025041215615766662
17,0.025041215615766662
monitoring,0.025041215615766662
various,0.024993246265534664
congenital,0.024993246265534664
followed,0.02468302880491304
primary,0.02468302880491304
computer,0.02461909536068488
effort,0.02461909536068488
attempts,0.02461909536068488
processing,0.02461909536068488
permission,0.02461909536068488
detailed,0.024246610422927157
included,0.024177725422119534
avoid,0.024104925223203132
questions,0.024104925223203132
10,0.02391168415475951
health,0.02391168415475951
falls,0.02374358395225793
status,0.023314235228472407
la,0.02327674600601007
commission,0.023170913280644592
network,0.023170913280644592
libertés,0.023170913280644592
clinique,0.023009246803966626
agency,0.022493921638981194
withdrawn,0.022493921638981194
leukocyte,0.022450745034825283
phase,0.022368994854452446
general,0.022306881589092983
provided,0.022306881589092983
sign,0.02191356838473012
governing,0.021722731200604306
situations,0.021722731200604306
order,0.02159765020429891
medium,0.02158725484117816
appropriate,0.02158725484117816
randomized,0.02158725484117816
design,0.0213370171721759
examination,0.0213370171721759
father,0.021244259325704465
regulations,0.021244259325704465
regulation,0.021244259325704465
nationale,0.021244259325704465
12,0.02082630555414538
days,0.02082630555414538
accordance,0.020817889965493615
abnormality,0.020817889965493615
comply,0.020817889965493615
european,0.020817889965493615
definition,0.020817889965493615
efficacy,0.02072376464753103
fully,0.02036715275525881
duplication,0.020274549120564016
randomization,0.020054960903991847
multicenter,0.019994597012427732
alive,0.019994597012427732
public,0.019994597012427732
internal,0.019994597012427732
stromal,0.019860274453883903
mesenchymal,0.019860274453883903
women,0.01972221154625711
saes,0.01972221154625711
forms,0.01972221154625711
enrolled,0.019397288338341725
specific,0.019283616253838315
function,0.018996784260236776
intended,0.01882636704052373
quickly,0.01882636704052373
mondor,0.01882636704052373
preservation,0.01882636704052373
unblinding,0.01882636704052373
make,0.018626533127020603
compliance,0.018626533127020603
end,0.01851227160368478
screening,0.01842742392142464
investigational,0.01842742392142464
implemented,0.01842742392142464
required,0.01813329406658965
death,0.017740926953531248
injection,0.017740926953531248
ii,0.017740926953531248
examinations,0.017530854707784097
outpatient,0.017530854707784097
recruited,0.017530854707784097
informed,0.017495272385874262
determine,0.01745755950450755
biological,0.01745755950450755
ml,0.01745755950450755
discontinued,0.01745755950450755
receive,0.01745755950450755
medicine,0.01745755950450755
scope,0.017378184960483444
tube,0.017378184960483444
obtain,0.017269803872942528
best,0.016969582303377716
sample,0.016487695087590466
procedures,0.016487695087590466
collect,0.016487695087590466
lack,0.01643517628854759
forced,0.01643517628854759
physical,0.01643517628854759
contact,0.01643517628854759
endpoint,0.0164063136792954
noted,0.016245610072597533
failed,0.016245610072597533
initially,0.016245610072597533
remains,0.016245610072597533
conducted,0.016245610072597533
recruiting,0.016245610072597533
weeks,0.016198237653224184
group,0.016198237653224184
administration,0.016198237653224184
secondary,0.016198237653224184
crfs,0.015930002880443158
baseline,0.015542823485648274
exposed,0.015542823485648274
total,0.015426893003070652
signs,0.015426893003070652
30,0.015426893003070652
purpose,0.015339497869311085
oncology,0.015339497869311085
identifying,0.014995947759320796
site,0.014995947759320796
open,0.014995947759320796
participating,0.014995947759320796
given,0.014679333292001146
life,0.01465554835291712
transplantation,0.01465554835291712
occurring,0.014547966253756294
law,0.014547966253756294
saint,0.014547966253756294
vital,0.014547966253756294
respond,0.014547966253756294
commitment,0.014481820800402872
creteil,0.014481820800402872
experimental,0.01381584309835402
serum,0.01381584309835402
36,0.01381584309835402
particularly,0.013746285446044065
ending,0.013746285446044065
protein,0.013578101836839208
identification,0.013578101836839208
table,0.013578101836839208
fertility,0.013148141030838074
affect,0.013148141030838074
board,0.013148141030838074
lesion,0.013148141030838074
electronic,0.013148141030838074
specify,0.013033638720362584
departments,0.013033638720362584
louis,0.012952352904706893
diseases,0.01260823741992212
analyzed,0.01260823741992212
thymoglobulin,0.01260823741992212
5mg,0.012496623132767332
childbearing,0.012496623132767332
2x106,0.012496623132767332
reported,0.01234151440245652
count,0.01234151440245652
20,0.01234151440245652
period,0.01234151440245652
stage,0.012088862711059767
pr,0.012088862711059767
investigators,0.012088862711059767
liver,0.012088862711059767
committee,0.012088862711059767
principal,0.012088862711059767
administered,0.012052462611601566
capacity,0.012052462611601566
physician,0.012052462611601566
ebv,0.011638373003005034
henri,0.011585456640322296
hospitals,0.011585456640322296
hematology,0.011585456640322296
pitie,0.011585456640322296
consult,0.011585456640322296
salpetriere,0.011585456640322296
france,0.011570169752302987
placebo,0.011570169752302987
donor,0.011570169752302987
capmatinib,0.011570169752302987
systemic,0.011570169752302987
tuberculosis,0.011246960819490597
local,0.011246960819490597
multi,0.011246960819490597
hepatitis,0.011246960819490597
48,0.011225372517412641
skin,0.011225372517412641
tubes,0.01095678419236506
methods,0.01095678419236506
virus,0.01095678419236506
exclusion,0.01095678419236506
ventricular,0.01095678419236506
plasma,0.010798825102149455
chimerism,0.010798825102149455
pre,0.010798825102149455
samples,0.010798825102149455
uveitis,0.010798825102149455
history,0.01066850858608795
enrolment,0.01066850858608795
described,0.01066850858608795
specified,0.010361882323765515
ratio,0.010361882323765515
prednisone,0.010361882323765515
antibodies,0.010361882323765515
tumor,0.010361882323765515
infectious,0.010361882323765515
anonymized,0.010137274560282008
copy,0.010137274560282008
collection,0.010027480451995923
stem,0.010027480451995923
response,0.010027480451995923
reviewed,0.009997298506213866
electrolytes,0.009997298506213866
sperm,0.009997298506213866
pharmacokinetic,0.009997298506213866
sirolimus,0.009997298506213866
cooperative,0.009997298506213866
referred,0.009997298506213866
medicinal,0.009861105773128554
corresponding,0.009861105773128554
carried,0.009861105773128554
medication,0.009861105773128554
stated,0.009861105773128554
validate,0.009861105773128554
rheumatology,0.009861105773128554
immunodeficiency,0.009861105773128554
nb,0.009861105773128554
volume,0.009861105773128554
hours,0.009698644169170862
age,0.009698644169170862
pulmonary,0.009698644169170862
expected,0.009698644169170862
identified,0.009698644169170862
cycle,0.009698644169170862
16,0.009498392130118388
different,0.009498392130118388
endpoints,0.009498392130118388
second,0.00925613580184239
infusion,0.00925613580184239
toxicity,0.00925613580184239
levels,0.00925613580184239
treated,0.00925613580184239
hematopoietic,0.00925613580184239
groups,0.00925613580184239
24,0.00925613580184239
storage,0.008765427353892049
controlled,0.008765427353892049
diagnosis,0.008765427353892049
scan,0.008765427353892049
circulating,0.008765427353892049
eligible,0.008765427353892049
special,0.008765427353892049
bayesian,0.008765427353892049
situation,0.008747636192937131
article,0.008747636192937131
200,0.008747636192937131
project,0.008747636192937131
electrophoresis,0.008747636192937131
serology,0.008747636192937131
reactions,0.008747636192937131
typing,0.008747636192937131
comorbidities,0.008747636192937131
final,0.008728779752253776
regimen,0.008728779752253776
area,0.008728779752253776
biopsy,0.008728779752253776
creatinine,0.008728779752253776
22,0.008728779752253776
106,0.008728779752253776
figure,0.008689092480241722
argenteuil,0.008689092480241722
created,0.008689092480241722
doctor,0.008689092480241722
consultation,0.008689092480241722
csm,0.008689092480241722
problem,0.008689092480241722
edta,0.008689092480241722
assessments,0.008689092480241722
likely,0.008689092480241722
multicentre,0.008689092480241722
single,0.008634901936471264
size,0.008634901936471264
allow,0.008634901936471264
appendix,0.008634901936471264
versus,0.008484791151688858
intravenous,0.008484791151688858
early,0.008484791151688858
potential,0.008484791151688858
met,0.008484791151688858
ongoing,0.008484791151688858
usual,0.007771411742824137
covid,0.007771411742824137
receiving,0.007771411742824137
course,0.007771411742824137
body,0.007771411742824137
free,0.007771411742824137
sclerosis,0.007771411742824137
imaging,0.007771411742824137
charge,0.00775891533533669
stopping,0.00775891533533669
performans,0.00775891533533669
pharmacodynamic,0.00775891533533669
oral,0.00775891533533669
weight,0.00775891533533669
05,0.00775891533533669
arms,0.00775891533533669
flare,0.00775891533533669
01,0.00775891533533669
maximum,0.00775891533533669
shown,0.00775891533533669
19,0.007713446501535326
quality,0.007713446501535326
associated,0.007713446501535326
graft,0.007713446501535326
duration,0.007713446501535326
dosage,0.007669748934655543
conditions,0.007669748934655543
sampling,0.007669748934655543
cohort,0.007669748934655543
pt,0.007669748934655543
fixed,0.007669748934655543
participate,0.007669748934655543
transmitted,0.007497973879660398
eastern,0.007497973879660398
application,0.007497973879660398
stable,0.007497973879660398
apply,0.007497973879660398
nature,0.007497973879660398
htlv,0.007497973879660398
rare,0.007497973879660398
rennes,0.007497973879660398
code,0.007497973879660398
ovarian,0.007497973879660398
units,0.007497973879660398
dry,0.007497973879660398
glucose,0.007497973879660398
gt,0.007497973879660398
telephone,0.007497973879660398
suspected,0.007497973879660398
mmr,0.007240910400201436
electrocardiogram,0.007240910400201436
modalities,0.007240910400201436
competent,0.007240910400201436
bichat,0.007240910400201436
develops,0.007240910400201436
amazzough,0.007240910400201436
presents,0.007240910400201436
technique,0.007240910400201436
q3w,0.007240910400201436
calcium,0.007240910400201436
relevant,0.007240910400201436
parallel,0.007240910400201436
annexe,0.007240910400201436
archival,0.007240910400201436
representative,0.007240910400201436
75010,0.007240910400201436
progression,0.006942101851381793
conditioning,0.006942101851381793
regulatory,0.00690792154917701
hospitalization,0.00690792154917701
cancer,0.00690792154917701
viral,0.00690792154917701
place,0.00690792154917701
score,0.00690792154917701
35,0.006789050918419604
hgf,0.006789050918419604
autoimmune,0.006789050918419604
practice,0.006789050918419604
recipient,0.006789050918419604
proposed,0.006789050918419604
gamma,0.006789050918419604
team,0.006789050918419604
alkaline,0.006574070515419037
replaced,0.006574070515419037
necessary,0.006574070515419037
doppler,0.006574070515419037
recently,0.006574070515419037
essential,0.006574070515419037
ejection,0.006574070515419037
men,0.006574070515419037
ferritin,0.006574070515419037
subcutaneously,0.006574070515419037
markers,0.006574070515419037
phosphatase,0.006574070515419037
stopped,0.006574070515419037
scd,0.006574070515419037
hemoglobin,0.006574070515419037
clinical,0.006574070515419037
urine,0.006574070515419037
400,0.006574070515419037
cmv,0.006574070515419037
investigating,0.006574070515419037
questionnaire,0.006574070515419037
planned,0.006574070515419037
summary,0.006574070515419037
hsv,0.006574070515419037
sante,0.006574070515419037
condition,0.006574070515419037
conduct,0.006574070515419037
physicians,0.006248311566383666
fev1,0.006248311566383666
transaminases,0.006248311566383666
serologies,0.006248311566383666
gastrectomy,0.006248311566383666
record,0.006248311566383666
fatal,0.006248311566383666
scheme,0.006248311566383666
hydroxyurea,0.006248311566383666
truncation,0.006248311566383666
inhibitors,0.006248311566383666
interruption,0.006248311566383666
coordinating,0.006248311566383666
cardiovascular,0.006248311566383666
guidelines,0.006248311566383666
anonymous,0.006248311566383666
contained,0.006248311566383666
propose,0.006248311566383666
ultrasound,0.006248311566383666
year,0.00617075720122826
host,0.00617075720122826
rate,0.00617075720122826
50,0.00617075720122826
40,0.00617075720122826
management,0.00617075720122826
post,0.00617075720122826
partial,0.006044431355529884
18,0.006044431355529884
occurrence,0.006044431355529884
frequency,0.006044431355529884
concerning,0.006044431355529884
long,0.006044431355529884
allogeneic,0.006044431355529884
spartalizumab,0.006044431355529884
25,0.006044431355529884
adult,0.006044431355529884
expression,0.005819186501502517
complementary,0.005819186501502517
ecog,0.005819186501502517
13,0.005819186501502517
comparing,0.005819186501502517
pcr,0.005819186501502517
involving,0.005819186501502517
renal,0.005819186501502517
cf,0.005792728320161148
accuracy,0.005792728320161148
office,0.005792728320161148
obesity,0.005792728320161148
fernand,0.005792728320161148
multicentric,0.005792728320161148
working,0.005792728320161148
professional,0.005792728320161148
predictive,0.005792728320161148
compatibility,0.005792728320161148
stimulation,0.005792728320161148
asked,0.005792728320161148
cover,0.005792728320161148
dsa,0.005792728320161148
height,0.005792728320161148
groupe,0.005792728320161148
luminex,0.005792728320161148
bilirubine,0.005792728320161148
richerand,0.005792728320161148
therapie,0.005792728320161148
verification,0.005792728320161148
tel,0.005792728320161148
request,0.005792728320161148
cellulaire,0.005792728320161148
technology,0.005792728320161148
investigations,0.005792728320161148
weekly,0.005792728320161148
widal,0.005792728320161148
clinic,0.00547839209618253
intravenously,0.00547839209618253
pharmacokinetics,0.00547839209618253
pediatric,0.00547839209618253
persons,0.00547839209618253
cross,0.00547839209618253
min,0.00547839209618253
stratified,0.00547839209618253
panel,0.00547839209618253
label,0.00547839209618253
paper,0.00547839209618253
ct,0.00547839209618253
sequential,0.00547839209618253
action,0.00547839209618253
tissue,0.00547839209618253
severity,0.005399412551074728
behcets,0.005399412551074728
probability,0.005399412551074728
unit,0.005399412551074728
corticosteroid,0.005399412551074728
60,0.005399412551074728
red,0.005399412551074728
high,0.005399412551074728
assessed,0.005399412551074728
failure,0.005399412551074728
observed,0.005399412551074728
marrow,0.005180941161882758
selection,0.005180941161882758
parameters,0.005180941161882758
requiring,0.005180941161882758
injected,0.005180941161882758
sites,0.005180941161882758
recommended,0.005180941161882758
des,0.005180941161882758
cycles,0.005180941161882758
adalimumab,0.005180941161882758
belimumab,0.005180941161882758
neutrophil,0.005180941161882758
threatening,0.005180941161882758
factors,0.005180941161882758
symptoms,0.005180941161882758
significant,0.005180941161882758
standardized,0.004998649253106933
discontinue,0.004998649253106933
smpc,0.004998649253106933
latest,0.004998649253106933
contraception,0.004998649253106933
containing,0.004998649253106933
hematocrit,0.004998649253106933
dyslipidemia,0.004998649253106933
magnesium,0.004998649253106933
takes,0.004998649253106933
alemtuzumab,0.004998649253106933
centralized,0.004998649253106933
delay,0.004998649253106933
intention,0.004998649253106933
immediately,0.004998649253106933
individual,0.004998649253106933
mentioned,0.004998649253106933
ptt,0.004998649253106933
aspiration,0.004998649253106933
feasibility,0.004998649253106933
prothrombin,0.004998649253106933
orr,0.004998649253106933
bias,0.004998649253106933
occur,0.004998649253106933
sectional,0.004998649253106933
practitioner,0.004998649253106933
determined,0.004849322084585431
rapidly,0.004849322084585431
surface,0.004849322084585431
biomedical,0.004849322084585431
sibling,0.004849322084585431
mycophenolate,0.004849322084585431
replacement,0.004849322084585431
reactive,0.004849322084585431
values,0.004849322084585431
continue,0.004849322084585431
cov,0.004849322084585431
genetic,0.004849322084585431
mofetil,0.004849322084585431
measurement,0.004849322084585431
search,0.004849322084585431
especially,0.004849322084585431
abo,0.004849322084585431
choice,0.004849322084585431
measures,0.004628067900921195
sars,0.004628067900921195
peripheral,0.004628067900921195
benefit,0.004628067900921195
therapy,0.004628067900921195
grade,0.004628067900921195
active,0.004628067900921195
extension,0.004382713676946024
thrombocytopenia,0.004382713676946024
neutropenia,0.004382713676946024
shall,0.004382713676946024
arterial,0.004382713676946024
combination,0.004382713676946024
checkpoint,0.004382713676946024
adherence,0.004382713676946024
simons,0.004382713676946024
rules,0.004382713676946024
maintain,0.004382713676946024
check,0.004382713676946024
blind,0.004382713676946024
l1,0.004382713676946024
sf,0.004382713676946024
important,0.004382713676946024
digestive,0.004382713676946024
inactive,0.004382713676946024
inference,0.004382713676946024
discretion,0.004382713676946024
determination,0.004382713676946024
depending,0.004382713676946024
intervention,0.004382713676946024
atlg,0.004382713676946024
myeloid,0.004382713676946024
hospitalier,0.004382713676946024
hospitalisation,0.004382713676946024
male,0.004382713676946024
frozen,0.004382713676946024
comprehensive,0.004344546240120861
members,0.004344546240120861
75011,0.004344546240120861
75017,0.004344546240120861
hdcy,0.004344546240120861
residence,0.004344546240120861
confidentiality,0.004344546240120861
7g,0.004344546240120861
causal,0.004344546240120861
peak,0.004344546240120861
26,0.004344546240120861
inherited,0.004344546240120861
200mg,0.004344546240120861
tacrolimus,0.004344546240120861
paragraph,0.004344546240120861
requested,0.004344546240120861
represented,0.004344546240120861
sampled,0.004344546240120861
writing,0.004344546240120861
fai2r,0.004344546240120861
practices,0.004344546240120861
thymo,0.004344546240120861
selected,0.004344546240120861
resulting,0.004344546240120861
cd3,0.004344546240120861
addressed,0.004344546240120861
ophthalmology,0.004344546240120861
7ml,0.004344546240120861
toulouse,0.004344546240120861
ethics,0.004344546240120861
apart,0.004344546240120861
listed,0.004344546240120861
marzouk,0.004344546240120861
referral,0.004344546240120861
right,0.004317450968235632
testing,0.004317450968235632
iii,0.004317450968235632
pembrolizumab,0.004317450968235632
radiation,0.004317450968235632
anemia,0.004317450968235632
camostat,0.004317450968235632
compared,0.004317450968235632
counts,0.004317450968235632
obtained,0.004317450968235632
reduction,0.004317450968235632
onset,0.004317450968235632
clearance,0.003879457667668345
white,0.003879457667668345
worsening,0.003879457667668345
29,0.003879457667668345
particular,0.003879457667668345
disorders,0.003879457667668345
interim,0.003879457667668345
treat,0.003879457667668345
blinded,0.003879457667668345
bone,0.003879457667668345
resonance,0.003879457667668345
300,0.003879457667668345
aims,0.003879457667668345
analysed,0.003879457667668345
developed,0.003879457667668345
respiratory,0.003879457667668345
authority,0.003879457667668345
association,0.003879457667668345
reduced,0.003879457667668345
recorded,0.003879457667668345
act,0.003879457667668345
twice,0.003879457667668345
positive,0.003879457667668345
adaptive,0.003879457667668345
graall,0.003879457667668345
terminology,0.003879457667668345
platelets,0.003879457667668345
entry,0.003879457667668345
aplastic,0.003879457667668345
magnetic,0.003879457667668345
grafalon,0.003879457667668345
responsible,0.003879457667668345
niu,0.003879457667668345
pressure,0.003879457667668345
common,0.003879457667668345
fact,0.003879457667668345
lesions,0.003856723250767663
vasculitis,0.003856723250767663
doses,0.003856723250767663
treatments,0.003856723250767663
previously,0.003856723250767663
survival,0.003856723250767663
concentration,0.003856723250767663
showing,0.003748986939830199
sufficient,0.003748986939830199
sickle,0.003748986939830199
showed,0.003748986939830199
feeding,0.003748986939830199
collaboration,0.003748986939830199
regarding,0.003748986939830199
concentrations,0.003748986939830199
prophylactic,0.003748986939830199
healthy,0.003748986939830199
entire,0.003748986939830199
gastroenterology,0.003748986939830199
ambulatory,0.003748986939830199
protocols,0.003748986939830199
way,0.003748986939830199
needed,0.003748986939830199
80c,0.003748986939830199
deficiency,0.003748986939830199
copies,0.003748986939830199
karyotype,0.003748986939830199
culture,0.003748986939830199
address,0.003748986939830199
oedema,0.003748986939830199
observation,0.003748986939830199
findings,0.003748986939830199
continued,0.003748986939830199
urinary,0.003748986939830199
trsae,0.003748986939830199
inclusions,0.003748986939830199
rna,0.003748986939830199
lariboisiere,0.003748986939830199
cap,0.003748986939830199
contain,0.003748986939830199
present,0.003453960774588505
perform,0.003453960774588505
decrease,0.003453960774588505
population,0.003453960774588505
cutaneous,0.003453960774588505
assess,0.003453960774588505
absence,0.003453960774588505
mean,0.003453960774588505
confirmed,0.003453960774588505
concomitant,0.003453960774588505
medications,0.003453960774588505
review,0.003453960774588505
kaposi,0.003453960774588505
received,0.003453960774588505
points,0.003453960774588505
considering,0.003453960774588505
eligibility,0.003453960774588505
identical,0.003453960774588505
antibody,0.003453960774588505
2013,0.003453960774588505
sle,0.003453960774588505
taken,0.003453960774588505
residual,0.003453960774588505
index,0.003453960774588505
myeloablative,0.0032870352577095184
cd4,0.0032870352577095184
mscs,0.0032870352577095184
stored,0.0032870352577095184
2017,0.0032870352577095184
statistical,0.0032870352577095184
outside,0.0032870352577095184
oxygen,0.0032870352577095184
ensuring,0.0032870352577095184
later,0.0032870352577095184
continuous,0.0032870352577095184
prescribed,0.0032870352577095184
fludrocortisone,0.0032870352577095184
transmission,0.0032870352577095184
carcinoma,0.0032870352577095184
safe,0.0032870352577095184
large,0.0032870352577095184
detection,0.0032870352577095184
relationship,0.0032870352577095184
applied,0.0032870352577095184
illness,0.0032870352577095184
identify,0.0032870352577095184
immunosuppression,0.0032870352577095184
amino,0.0032870352577095184
hydrocortisone,0.0032870352577095184
birth,0.0032870352577095184
half,0.0032870352577095184
inform,0.0032870352577095184
breast,0.0032870352577095184
v3,0.0032870352577095184
saturation,0.0032870352577095184
rule,0.0032870352577095184
bilirubin,0.0032870352577095184
enrollment,0.0032870352577095184
assigned,0.0032870352577095184
transferase,0.0032870352577095184
unless,0.0032870352577095184
cd19,0.0032870352577095184
curve,0.0032870352577095184
binary,0.0032870352577095184
glucocorticoids,0.0032870352577095184
immune,0.00308537860061413
optimal,0.00308537860061413
recommendations,0.00308537860061413
cryoglobulinemia,0.00308537860061413
activity,0.00308537860061413
characteristics,0.00308537860061413
macular,0.00308537860061413
55,0.00308537860061413
70,0.00308537860061413
infection,0.00308537860061413
remission,0.00308537860061413
haplo,0.00308537860061413
coherence,0.0029095932507512585
gene,0.0029095932507512585
recent,0.0029095932507512585
mesylate,0.0029095932507512585
uncontrolled,0.0029095932507512585
prophylaxis,0.0029095932507512585
unacceptable,0.0029095932507512585
lymphocytes,0.0029095932507512585
consumption,0.0029095932507512585
lymphocyte,0.0029095932507512585
optical,0.0029095932507512585
analyses,0.0029095932507512585
individuals,0.0029095932507512585
infliximab,0.0029095932507512585
institute,0.0029095932507512585
transplanted,0.0029095932507512585
allowing,0.0029095932507512585
impact,0.0029095932507512585
allows,0.0029095932507512585
immediate,0.0029095932507512585
donors,0.0029095932507512585
du,0.0029095932507512585
responders,0.0029095932507512585
dna,0.0029095932507512585
hypertension,0.0029095932507512585
relative,0.0029095932507512585
21,0.0029095932507512585
30min,0.002896364160080574
evaluations,0.002896364160080574
schedules,0.002896364160080574
explorations,0.002896364160080574
feature,0.002896364160080574
sinus,0.002896364160080574
1h,0.002896364160080574
pfu,0.002896364160080574
ihc,0.002896364160080574
occupational,0.002896364160080574
unblinded,0.002896364160080574
melun,0.002896364160080574
melanoma,0.002896364160080574
sex,0.002896364160080574
registered,0.002896364160080574
4ml,0.002896364160080574
mathec,0.002896364160080574
simplicity,0.002896364160080574
unite,0.002896364160080574
unexposed,0.002896364160080574
techniques,0.002896364160080574
cd56,0.002896364160080574
measurements,0.002896364160080574
sud,0.002896364160080574
amh,0.002896364160080574
characterized,0.002896364160080574
maladies,0.002896364160080574
examples,0.002896364160080574
assistants,0.002896364160080574
ile,0.002896364160080574
flexibility,0.002896364160080574
ekg,0.002896364160080574
jean,0.002896364160080574
le,0.002896364160080574
cleanweb,0.002896364160080574
sur,0.002896364160080574
gastric,0.002896364160080574
nct02795429,0.002896364160080574
2mg,0.002896364160080574
volunteers,0.002896364160080574
stress,0.002896364160080574
cmax,0.002896364160080574
envelope,0.002896364160080574
paramedical,0.002896364160080574
rct,0.002896364160080574
ghsif,0.002896364160080574
investigation,0.002896364160080574
justification,0.002896364160080574
surname,0.002896364160080574
recall,0.002896364160080574
consist,0.002896364160080574
les,0.002896364160080574
knowing,0.002896364160080574
systematically,0.002896364160080574
universitaire,0.002896364160080574
cd14,0.002896364160080574
programs,0.002896364160080574
occurred,0.002896364160080574
enrollments,0.002896364160080574
retained,0.002896364160080574
letter,0.002896364160080574
dates,0.002896364160080574
archiving,0.002896364160080574
slow,0.002896364160080574
informations,0.002896364160080574
paxgene,0.002896364160080574
puncture,0.002896364160080574
randomised,0.002896364160080574
liquid,0.002896364160080574
offers,0.002896364160080574
39,0.002896364160080574
purposes,0.002896364160080574
boundaries,0.002896364160080574
realize,0.002896364160080574
notebook,0.002896364160080574
ono,0.002896364160080574
industrial,0.002896364160080574
tropical,0.002896364160080574
gy,0.002896364160080574
nuclear,0.002896364160080574
hand,0.002896364160080574
teleconsultation,0.002896364160080574
pooled,0.002896364160080574
cyclophosphamide,0.002590470580941379
nk,0.002590470580941379
nomenclature,0.002590470580941379
central,0.002590470580941379
point,0.002590470580941379
follows,0.002590470580941379
release,0.002590470580941379
corticosteroids,0.002590470580941379
ensure,0.002590470580941379
minimal,0.002590470580941379
matched,0.002590470580941379
standardization,0.002590470580941379
uninjected,0.002590470580941379
double,0.002590470580941379
approach,0.002590470580941379
notably,0.002590470580941379
evaluated,0.002590470580941379
tocilizumab,0.002590470580941379
presence,0.002590470580941379
loss,0.002590470580941379
refer,0.002590470580941379
heart,0.002590470580941379
good,0.002590470580941379
45,0.002590470580941379
reduce,0.002590470580941379
inhibitor,0.002590470580941379
infusions,0.002590470580941379
malignancy,0.0024993246265534665
example,0.0024993246265534665
scientific,0.0024993246265534665
spermogram,0.0024993246265534665
planning,0.0024993246265534665
avoiding,0.0024993246265534665
20mg,0.0024993246265534665
situ,0.0024993246265534665
ancillary,0.0024993246265534665
hcg,0.0024993246265534665
1mg,0.0024993246265534665
worthy,0.0024993246265534665
subpopulations,0.0024993246265534665
submitted,0.0024993246265534665
excessive,0.0024993246265534665
stabilization,0.0024993246265534665
disability,0.0024993246265534665
head,0.0024993246265534665
diaphragm,0.0024993246265534665
concerns,0.0024993246265534665
designs,0.0024993246265534665
donnees,0.0024993246265534665
small,0.0024993246265534665
subcutaneous,0.0024993246265534665
comité,0.0024993246265534665
moment,0.0024993246265534665
vitro,0.0024993246265534665
compatible,0.0024993246265534665
result,0.0024993246265534665
obtaining,0.0024993246265534665
personnes,0.0024993246265534665
igra,0.0024993246265534665
started,0.0024993246265534665
stages,0.0024993246265534665
hypersensitivity,0.0024993246265534665
signing,0.0024993246265534665
implies,0.0024993246265534665
increasing,0.0024993246265534665
indication,0.0024993246265534665
suggestive,0.0024993246265534665
suggested,0.0024993246265534665
cessation,0.0024993246265534665
consistent,0.0024993246265534665
agence,0.0024993246265534665
field,0.0024993246265534665
corresponds,0.0024993246265534665
adjudication,0.0024993246265534665
partner,0.0024993246265534665
provides,0.0024993246265534665
appendices,0.0024993246265534665
allergic,0.0024993246265534665
diameter,0.0024993246265534665
device,0.0024993246265534665
betamethasone,0.0024993246265534665
biobanking,0.0024993246265534665
immunology,0.0024993246265534665
vasoconstrictor,0.0024993246265534665
blinding,0.0024993246265534665
blocks,0.0024993246265534665
healthcare,0.0024993246265534665
supervision,0.0024993246265534665
maintained,0.0024993246265534665
condom,0.0024993246265534665
cancers,0.0024993246265534665
uc,0.0024993246265534665
c2d1,0.0024993246265534665
43,0.0024993246265534665
leading,0.0024993246265534665
error,0.0024993246265534665
premedication,0.0024993246265534665
replete,0.0024993246265534665
requires,0.0024993246265534665
country,0.0024993246265534665
validity,0.0024993246265534665
involves,0.0024993246265534665
participated,0.0024993246265534665
investigated,0.0024993246265534665
ray,0.0024993246265534665
rarely,0.0024993246265534665
confirmation,0.0024993246265534665
considers,0.0024993246265534665
knowledge,0.0024993246265534665
contraceptive,0.0024993246265534665
sealed,0.0024993246265534665
close,0.0024993246265534665
chu,0.0024993246265534665
gel,0.0024993246265534665
irradiation,0.0024993246265534665
isoniazid,0.0024993246265534665
actually,0.0024993246265534665
proposal,0.0024993246265534665
kept,0.0024993246265534665
cream,0.0024993246265534665
stop,0.0024993246265534665
nih,0.0024993246265534665
cm,0.0024993246265534665
auto,0.0024993246265534665
relapsing,0.0024993246265534665
young,0.0024993246265534665
27,0.0024993246265534665
evidence,0.0023140339504605974
evolution,0.0023140339504605974
relapse,0.0023140339504605974
posterior,0.0023140339504605974
decision,0.0023140339504605974
retinal,0.0023140339504605974
refractory,0.0023140339504605974
modified,0.0023140339504605974
model,0.0023140339504605974
resolution,0.0023140339504605974
multiple,0.0023140339504605974
sensitivity,0.0023140339504605974
available,0.0023140339504605974
eye,0.0023140339504605974
amplification,0.0023140339504605974
independent,0.0023140339504605974
increase,0.0023140339504605974
ocular,0.0023140339504605974
keytruda,0.002191356838473012
range,0.002191356838473012
strong,0.002191356838473012
chest,0.002191356838473012
phenotyping,0.002191356838473012
allocated,0.002191356838473012
derived,0.002191356838473012
informative,0.002191356838473012
alanine,0.002191356838473012
adenocarcinoma,0.002191356838473012
appears,0.002191356838473012
recurrence,0.002191356838473012
borr,0.002191356838473012
unique,0.002191356838473012
died,0.002191356838473012
access,0.002191356838473012
2005,0.002191356838473012
agreed,0.002191356838473012
orally,0.002191356838473012
40mg,0.002191356838473012
aspartate,0.002191356838473012
basis,0.002191356838473012
deaths,0.002191356838473012
c30,0.002191356838473012
prescription,0.002191356838473012
intervals,0.002191356838473012
leukemia,0.002191356838473012
intensity,0.002191356838473012
proportions,0.002191356838473012
prospective,0.002191356838473012
epidemiology,0.002191356838473012
eortc,0.002191356838473012
attenuated,0.002191356838473012
recipients,0.002191356838473012
28,0.002191356838473012
qlq,0.002191356838473012
documentation,0.002191356838473012
established,0.002191356838473012
diagnosed,0.002191356838473012
times,0.002191356838473012
extensive,0.002191356838473012
registry,0.002191356838473012
missing,0.002191356838473012
charlson,0.002191356838473012
scheduled,0.002191356838473012
assay,0.002191356838473012
sedimentation,0.002191356838473012
comparative,0.002191356838473012
hepatic,0.002191356838473012
haploidentical,0.002191356838473012
109,0.002191356838473012
150,0.002191356838473012
objectives,0.002191356838473012
mass,0.002191356838473012
aminotransferase,0.002191356838473012
diabetes,0.002191356838473012
malignancies,0.002191356838473012
products,0.002191356838473012
disorder,0.002191356838473012
direct,0.002191356838473012
description,0.002191356838473012
agents,0.002191356838473012
echocardiography,0.002191356838473012
scores,0.0019397288338341724
decreased,0.0019397288338341724
initiation,0.0019397288338341724
intermediate,0.0019397288338341724
version,0.0019397288338341724
cumulative,0.0019397288338341724
voc,0.0019397288338341724
modification,0.0019397288338341724
meet,0.0019397288338341724
cohorts,0.0019397288338341724
absolute,0.0019397288338341724
method,0.0019397288338341724
hopital,0.0019397288338341724
profile,0.0019397288338341724
observations,0.0019397288338341724
directly,0.0019397288338341724
set,0.0019397288338341724
setting,0.0019397288338341724
documented,0.0019397288338341724
indexed,0.0019397288338341724
american,0.0019397288338341724
currently,0.0019397288338341724
known,0.0019397288338341724
attributed,0.0019397288338341724
ion,0.0019397288338341724
require,0.0019397288338341724
clinically,0.0019397288338341724
negative,0.0019397288338341724
nervous,0.0019397288338341724
potentially,0.0019397288338341724
tomography,0.0019397288338341724
mud,0.0019397288338341724
injections,0.0019397288338341724
target,0.0019397288338341724
immunogenicity,0.0019397288338341724
difference,0.0019397288338341724
allo,0.0019397288338341724
lung,0.0019397288338341724
causes,0.0019397288338341724
treosulfan,0.0019397288338341724
aml,0.0019397288338341724
cytokine,0.0019397288338341724
adequate,0.0019397288338341724
role,0.0019397288338341724
beta,0.0019397288338341724
limit,0.0019397288338341724
500,0.0019397288338341724
occurs,0.0019397288338341724
80mg,0.0019397288338341724
acs,0.0019397288338341724
respectively,0.0019397288338341724
hydrogen,0.0019397288338341724
fish,0.0019397288338341724
80,0.0017269803872942526
higher,0.0017269803872942526
mds,0.0017269803872942526
11,0.0017269803872942526
comparison,0.0017269803872942526
delayed,0.0017269803872942526
late,0.0017269803872942526
international,0.0017269803872942526
sct,0.0017269803872942526
ks,0.0017269803872942526
responses,0.0017269803872942526
100,0.0017269803872942526
need,0.0017269803872942526
support,0.0017269803872942526
interaction,0.0017269803872942526
outcomes,0.0017269803872942526
mortality,0.0017269803872942526
scale,0.0017269803872942526
factor,0.0017269803872942526
normal,0.0017269803872942526
incidence,0.0017269803872942526
starting,0.0017269803872942526
antibiotic,0.0017269803872942526
change,0.0017269803872942526
inflammatory,0.0017269803872942526
inflammation,0.0017269803872942526
term,0.0017269803872942526
vascular,0.0017269803872942526
2012,0.0017269803872942526
type,0.0017269803872942526
platelet,0.0017269803872942526
tolerance,0.0017269803872942526
sparing,0.0017269803872942526
syndrome,0.001542689300307065
acute,0.001542689300307065
involvement,0.001542689300307065
chronic,0.001542689300307065
current,0.001542689300307065
poor,0.001542689300307065
daily,0.001542689300307065
increased,0.001542689300307065
main,0.001542689300307065
value,0.001542689300307065
infections,0.001542689300307065
greater,0.001542689300307065
complications,0.001542689300307065
steroid,0.001542689300307065
tnf,0.001542689300307065
124,0.001448182080040287
wittes,0.001448182080040287
work,0.001448182080040287
110,0.001448182080040287
600mg,0.001448182080040287
324,0.001448182080040287
344,0.001448182080040287
6mg,0.001448182080040287
46,0.001448182080040287
sharma,0.001448182080040287
sections,0.001448182080040287
semi,0.001448182080040287
microsatellite,0.001448182080040287
modelling,0.001448182080040287
modifications,0.001448182080040287
montpellier,0.001448182080040287
mrt,0.001448182080040287
87,0.001448182080040287
8mg,0.001448182080040287
96,0.001448182080040287
accumulated,0.001448182080040287
achievable,0.001448182080040287
acting,0.001448182080040287
separate,0.001448182080040287
separated,0.001448182080040287
scl,0.001448182080040287
suited,0.001448182080040287
making,0.001448182080040287
managed,0.001448182080040287
maria,0.001448182080040287
maximal,0.001448182080040287
modify,0.001448182080040287
added,0.001448182080040287
addenda,0.001448182080040287
verify,0.001448182080040287
vincent,0.001448182080040287
adipose,0.001448182080040287
advantage,0.001448182080040287
acts,0.001448182080040287
agreeing,0.001448182080040287
options,0.001448182080040287
living,0.001448182080040287
supervised,0.001448182080040287
supplementary,0.001448182080040287
lungs,0.001448182080040287
lyon,0.001448182080040287
subsequently,0.001448182080040287
substantial,0.001448182080040287
animals,0.001448182080040287
alloantibodies,0.001448182080040287
allocation,0.001448182080040287
vd,0.001448182080040287
anticipate,0.001448182080040287
valued,0.001448182080040287
skins,0.001448182080040287
route,0.001448182080040287
routinely,0.001448182080040287
rubi,0.001448182080040287
run,0.001448182080040287
paracetamol,0.001448182080040287
leave,0.001448182080040287
leclerc,0.001448182080040287
kit,0.001448182080040287
lan,0.001448182080040287
opportunity,0.001448182080040287
antral,0.001448182080040287
associations,0.001448182080040287
approval,0.001448182080040287
aptt,0.001448182080040287
ar,0.001448182080040287
balance,0.001448182080040287
restricted,0.001448182080040287
retina,0.001448182080040287
jh,0.001448182080040287
johnson,0.001448182080040287
justified,0.001448182080040287
kt,0.001448182080040287
lacking,0.001448182080040287
ivanova,0.001448182080040287
jet,0.001448182080040287
owing,0.001448182080040287
oxymeter,0.001448182080040287
paediatric,0.001448182080040287
retrieved,0.001448182080040287
baltimore,0.001448182080040287
baron,0.001448182080040287
bayes,0.001448182080040287
behalf,0.001448182080040287
benlysta,0.001448182080040287
v2,0.001448182080040287
validation,0.001448182080040287
biased,0.001448182080040287
binders,0.001448182080040287
rescue,0.001448182080040287
invest,0.001448182080040287
inr,0.001448182080040287
institutions,0.001448182080040287
interventions,0.001448182080040287
intraveinously,0.001448182080040287
parties,0.001448182080040287
suspended,0.001448182080040287
tapering,0.001448182080040287
immunomodulator,0.001448182080040287
induce,0.001448182080040287
inflation,0.001448182080040287
pathologic,0.001448182080040287
pbsc,0.001448182080040287
ped,0.001448182080040287
inefficacious,0.001448182080040287
respected,0.001448182080040287
v0,0.001448182080040287
boutboul,0.001448182080040287
bradycardia,0.001448182080040287
browser,0.001448182080040287
cancerologie,0.001448182080040287
representing,0.001448182080040287
unlikely,0.001448182080040287
urc,0.001448182080040287
causing,0.001448182080040287
cd34,0.001448182080040287
heterogeneity,0.001448182080040287
hold,0.001448182080040287
hour,0.001448182080040287
hyperthermia,0.001448182080040287
hypofertility,0.001448182080040287
hypotension,0.001448182080040287
identity,0.001448182080040287
staggered,0.001448182080040287
perfusion,0.001448182080040287
immunes,0.001448182080040287
cedex,0.001448182080040287
challenge,0.001448182080040287
characteristic,0.001448182080040287
unemployment,0.001448182080040287
chronology,0.001448182080040287
chru,0.001448182080040287
cl,0.001448182080040287
relies,0.001448182080040287
removal,0.001448182080040287
goes,0.001448182080040287
going,0.001448182080040287
guideline,0.001448182080040287
gregory,0.001448182080040287
hepatocellular,0.001448182080040287
hepatocyte,0.001448182080040287
clinicians,0.001448182080040287
collects,0.001448182080040287
colorectal,0.001448182080040287
companies,0.001448182080040287
uncertainty,0.001448182080040287
compound,0.001448182080040287
registration,0.001448182080040287
francais,0.001448182080040287
francois,0.001448182080040287
follicle,0.001448182080040287
gender,0.001448182080040287
georges,0.001448182080040287
possibility,0.001448182080040287
regurgitant,0.001448182080040287
rejected,0.001448182080040287
consented,0.001448182080040287
types,0.001448182080040287
ulcer,0.001448182080040287
realized,0.001448182080040287
consults,0.001448182080040287
contribute,0.001448182080040287
finished,0.001448182080040287
farge,0.001448182080040287
faster,0.001448182080040287
feasible,0.001448182080040287
forwarded,0.001448182080040287
fraall2000,0.001448182080040287
fictive,0.001448182080040287
filiere,0.001448182080040287
predictor,0.001448182080040287
consequences,0.001448182080040287
consists,0.001448182080040287
correspondence,0.001448182080040287
corticoids,0.001448182080040287
corticotrophin,0.001448182080040287
council,0.001448182080040287
continuation,0.001448182080040287
cps,0.001448182080040287
coordinator,0.001448182080040287
ranging,0.001448182080040287
crocchiolo,0.001448182080040287
cut,0.001448182080040287
cutanee,0.001448182080040287
prof,0.001448182080040287
profiling,0.001448182080040287
profound,0.001448182080040287
thirty,0.001448182080040287
thymoglobuline,0.001448182080040287
fetal,0.001448182080040287
price,0.001448182080040287
practical,0.001448182080040287
practitioners,0.001448182080040287
evolving,0.001448182080040287
tmax,0.001448182080040287
exhaustive,0.001448182080040287
experiments,0.001448182080040287
explain,0.001448182080040287
explanation,0.001448182080040287
proceed,0.001448182080040287
productivity,0.001448182080040287
cytof,0.001448182080040287
cytogenetics,0.001448182080040287
cytopenias,0.001448182080040287
database,0.001448182080040287
decide,0.001448182080040287
defect,0.001448182080040287
rares,0.001448182080040287
quarterly,0.001448182080040287
quasi,0.001448182080040287
efferocytosis,0.001448182080040287
elimination,0.001448182080040287
ellenberg,0.001448182080040287
enclosed,0.001448182080040287
eot,0.001448182080040287
topoisomerase,0.001448182080040287
traditional,0.001448182080040287
promoter,0.001448182080040287
eradicate,0.001448182080040287
establish,0.001448182080040287
dermatology,0.001448182080040287
treg,0.001448182080040287
tried,0.001448182080040287
devillier,0.001448182080040287
demets,0.001448182080040287
depend,0.001448182080040287
randomize,0.001448182080040287
publication,0.001448182080040287
pugnet,0.001448182080040287
sofa,0.001448182080040287
soluble,0.001448182080040287
doesnt,0.001448182080040287
dominique,0.001448182080040287
dosing,0.001448182080040287
driven,0.001448182080040287
dsi,0.001448182080040287
duplicate,0.001448182080040287
protease,0.001448182080040287
proton,0.001448182080040287
provisions,0.001448182080040287
engagement,0.001448182080040287
pump,0.001448182080040287
pursuant,0.001448182080040287
diarrhea,0.001448182080040287
dimension,0.001448182080040287
discovered,0.001448182080040287
disposition,0.001448182080040287
distributed,0.001448182080040287
qql,0.001448182080040287
qualified,0.001448182080040287
sm,0.001448182080040287
want,0.001448182080040287
31,0.001448182080040287
225,0.001448182080040287
23,0.001448182080040287
simulations,0.001448182080040287
seven,0.001448182080040287
4mg,0.001448182080040287
57,0.001448182080040287
multiplicity,0.001448182080040287
muscles,0.001448182080040287
naive,0.001448182080040287
nasopharyngeal,0.001448182080040287
necessarily,0.001448182080040287
172,0.001448182080040287
wish,0.001448182080040287
1994,0.0012496623132767332
162,0.0012496623132767332
150mg,0.0012496623132767332
1500,0.0012496623132767332
nelarabine,0.0012496623132767332
necker,0.0012496623132767332
nausea,0.0012496623132767332
n1,0.0012496623132767332
multidisciplinary,0.0012496623132767332
5d,0.0012496623132767332
56,0.0012496623132767332
simon,0.0012496623132767332
3mg,0.0012496623132767332
37,0.0012496623132767332
36v2,0.0012496623132767332
30g,0.0012496623132767332
wang,0.0012496623132767332
quantiferon,0.0012496623132767332
distance,0.0012496623132767332
discussed,0.0012496623132767332
detecting,0.0012496623132767332
dilatation,0.0012496623132767332
pulse,0.0012496623132767332
spending,0.0012496623132767332
droplet,0.0012496623132767332
dramatically,0.0012496623132767332
donation,0.0012496623132767332
randomisation,0.0012496623132767332
dependent,0.0012496623132767332
dendritic,0.0012496623132767332
demyelinating,0.0012496623132767332
tricuspid,0.0012496623132767332
treating,0.0012496623132767332
transthoracic,0.0012496623132767332
excipients,0.0012496623132767332
proposes,0.0012496623132767332
prolonged,0.0012496623132767332
eq,0.0012496623132767332
transferrin,0.0012496623132767332
efficiency,0.0012496623132767332
derivatives,0.0012496623132767332
rationale,0.0012496623132767332
dedicated,0.0012496623132767332
decisions,0.0012496623132767332
troubles,0.0012496623132767332
cy,0.0012496623132767332
countries,0.0012496623132767332
produits,0.0012496623132767332
process,0.0012496623132767332
experts,0.0012496623132767332
existing,0.0012496623132767332
excluding,0.0012496623132767332
exam,0.0012496623132767332
explore,0.0012496623132767332
enrol,0.0012496623132767332
financial,0.0012496623132767332
preventing,0.0012496623132767332
extracted,0.0012496623132767332
external,0.0012496623132767332
fewer,0.0012496623132767332
female,0.0012496623132767332
program,0.0012496623132767332
ctfg,0.0012496623132767332
cord,0.0012496623132767332
corpuscular,0.0012496623132767332
globulin,0.0012496623132767332
poorly,0.0012496623132767332
policy,0.0012496623132767332
fields,0.0012496623132767332
framework,0.0012496623132767332
fleming,0.0012496623132767332
finite,0.0012496623132767332
conversely,0.0012496623132767332
controlling,0.0012496623132767332
consultations,0.0012496623132767332
reducing,0.0012496623132767332
tyrosine,0.0012496623132767332
tumors,0.0012496623132767332
confounding,0.0012496623132767332
confounders,0.0012496623132767332
glomerulonephritis,0.0012496623132767332
thanks,0.0012496623132767332
testosterone,0.0012496623132767332
phosphate,0.0012496623132767332
philadelphia,0.0012496623132767332
graall2003,0.0012496623132767332
fluids,0.0012496623132767332
futility,0.0012496623132767332
fsh,0.0012496623132767332
frequent,0.0012496623132767332
register,0.0012496623132767332
regional,0.0012496623132767332
refusal,0.0012496623132767332
composed,0.0012496623132767332
unable,0.0012496623132767332
umbilical,0.0012496623132767332
commonly,0.0012496623132767332
conclusions,0.0012496623132767332
collections,0.0012496623132767332
ss,0.0012496623132767332
squamous,0.0012496623132767332
spot,0.0012496623132767332
sponge,0.0012496623132767332
greatly,0.0012496623132767332
held,0.0012496623132767332
haemoglobin,0.0012496623132767332
hads,0.0012496623132767332
goal,0.0012496623132767332
glucocorticoid,0.0012496623132767332
clin,0.0012496623132767332
claude,0.0012496623132767332
repair,0.0012496623132767332
cervix,0.0012496623132767332
undergo,0.0012496623132767332
chapter,0.0012496623132767332
cd38,0.0012496623132767332
immuno,0.0012496623132767332
performing,0.0012496623132767332
ig,0.0012496623132767332
ib,0.0012496623132767332
immunologic,0.0012496623132767332
hbs,0.0012496623132767332
carrying,0.0012496623132767332
breastfeeding,0.0012496623132767332
bolus,0.0012496623132767332
blockade,0.0012496623132767332
respective,0.0012496623132767332
introducing,0.0012496623132767332
past,0.0012496623132767332
partners,0.0012496623132767332
incorporating,0.0012496623132767332
influenza,0.0012496623132767332
tachycardia,0.0012496623132767332
sécurité,0.0012496623132767332
improved,0.0012496623132767332
susceptible,0.0012496623132767332
investment,0.0012496623132767332
parity,0.0012496623132767332
intra,0.0012496623132767332
interview,0.0012496623132767332
interpreted,0.0012496623132767332
internet,0.0012496623132767332
switzerland,0.0012496623132767332
insufficiency,0.0012496623132767332
resources,0.0012496623132767332
rifampicin,0.0012496623132767332
v1,0.0012496623132767332
basal,0.0012496623132767332
ric,0.0012496623132767332
ovulation,0.0012496623132767332
issues,0.0012496623132767332
lactate,0.0012496623132767332
laboratoire,0.0012496623132767332
joints,0.0012496623132767332
sustaining,0.0012496623132767332
reticulocyte,0.0012496623132767332
bacterial,0.0012496623132767332
background,0.0012496623132767332
avenue,0.0012496623132767332
availability,0.0012496623132767332
auricular,0.0012496623132767332
archived,0.0012496623132767332
asthma,0.0012496623132767332
optional,0.0012496623132767332
opioids,0.0012496623132767332
light,0.0012496623132767332
ligand,0.0012496623132767332
lifestyle,0.0012496623132767332
lh,0.0012496623132767332
kinase,0.0012496623132767332
ldh,0.0012496623132767332
latent,0.0012496623132767332
opioid,0.0012496623132767332
rnaemia,0.0012496623132767332
slicc,0.0012496623132767332
variants,0.0012496623132767332
variables,0.0012496623132767332
applies,0.0012496623132767332
applicable,0.0012496623132767332
anticoagulants,0.0012496623132767332
venous,0.0012496623132767332
velocity,0.0012496623132767332
vellefaux,0.0012496623132767332
sizes,0.0012496623132767332
siti,0.0012496623132767332
anaphylactic,0.0012496623132767332
analyse,0.0012496623132767332
antiviral,0.0012496623132767332
antinuclear,0.0012496623132767332
antigens,0.0012496623132767332
affiliated,0.0012496623132767332
amenorrhea,0.0012496623132767332
alternatively,0.0012496623132767332
alloreactive,0.0012496623132767332
nursing,0.0012496623132767332
null,0.0012496623132767332
olivier,0.0012496623132767332
oestrogen,0.0012496623132767332
lymphoid,0.0012496623132767332
superiority,0.0012496623132767332
ll03,0.0012496623132767332
majority,0.0012496623132767332
adequately,0.0012496623132767332
saliva,0.0012496623132767332
secondly,0.0012496623132767332
actual,0.0012496623132767332
activities,0.0012496623132767332
administrated,0.0012496623132767332
versions,0.0012496623132767332
verified,0.0012496623132767332
microg,0.0012496623132767332
matching,0.0012496623132767332
meetings,0.0012496623132767332
obstructive,0.0012496623132767332
obrien,0.0012496623132767332
medicament,0.0012496623132767332
suggesting,0.0012496623132767332
suggest,0.0012496623132767332
successive,0.0012496623132767332
successfully,0.0012496623132767332
scleroderma,0.0012496623132767332
accrual,0.0012496623132767332
accepted,0.0012496623132767332
abdominal,0.0012496623132767332
94,0.0012496623132767332
91,0.0012496623132767332
activated,0.0012496623132767332
noninfectious,0.0012496623132767332
stevens,0.0012496623132767332
strictly,0.0012496623132767332
stratum,0.0012496623132767332
mos,0.0012496623132767332
mononeuropathy,0.0012496623132767332
monocytes,0.0012496623132767332
mn,0.0012496623132767332
subgroup,0.0012496623132767332
studied,0.0012496623132767332
millimeter,0.0012496623132767332
shock,0.0012496623132767332
sharing,0.0012496623132767332
sf36,0.0012496623132767332
7mg,0.0012496623132767332
75475,0.0012496623132767332
75,0.0012496623132767332
66,0.0012496623132767332
5ml,0.0012496623132767332
walk,0.0012496623132767332
vomiting,0.0012496623132767332
2021,0.0012496623132767332
2020,0.0012496623132767332
willingness,0.0012496623132767332
1000,0.0012496623132767332
03,0.0012496623132767332
02,0.0012496623132767332
zone,0.0012496623132767332
1121,0.0012496623132767332
vs,0.001095678419236506
zero,0.001095678419236506
2015,0.001095678419236506
similar,0.001095678419236506
similarly,0.001095678419236506
affected,0.001095678419236506
advanced,0.001095678419236506
adults,0.001095678419236506
air,0.001095678419236506
alternative,0.001095678419236506
angiography,0.001095678419236506
analyze,0.001095678419236506
vasopressors,0.001095678419236506
priapism,0.001095678419236506
prevention,0.001095678419236506
prevent,0.001095678419236506
profiles,0.001095678419236506
prospectively,0.001095678419236506
psychiatric,0.001095678419236506
provisional,0.001095678419236506
proteinuria,0.001095678419236506
random,0.001095678419236506
radiological,0.001095678419236506
questionnaires,0.001095678419236506
old,0.001095678419236506
osteonecrosis,0.001095678419236506
option,0.001095678419236506
pga,0.001095678419236506
sri,0.001095678419236506
apn,0.001095678419236506
anxiety,0.001095678419236506
approximately,0.001095678419236506
atrial,0.001095678419236506
autoantibodies,0.001095678419236506
authorized,0.001095678419236506
authorization,0.001095678419236506
base,0.001095678419236506
biology,0.001095678419236506
binomial,0.001095678419236506
bilag,0.001095678419236506
v4,0.001095678419236506
strategy,0.001095678419236506
ms,0.001095678419236506
monotherapy,0.001095678419236506
mononuclear,0.001095678419236506
nasal,0.001095678419236506
myocarditis,0.001095678419236506
murine,0.001095678419236506
necrosis,0.001095678419236506
newly,0.001095678419236506
nephropathy,0.001095678419236506
block,0.001095678419236506
c4,0.001095678419236506
c3,0.001095678419236506
brochure,0.001095678419236506
cd8,0.001095678419236506
upper,0.001095678419236506
undergoing,0.001095678419236506
metabolic,0.001095678419236506
medullar,0.001095678419236506
medicines,0.001095678419236506
minor,0.001095678419236506
minimum,0.001095678419236506
microalbuminuria,0.001095678419236506
metastatic,0.001095678419236506
molecular,0.001095678419236506
subpopulation,0.001095678419236506
characterize,0.001095678419236506
ch50,0.001095678419236506
chose,0.001095678419236506
chorioretinal,0.001095678419236506
college,0.001095678419236506
complement,0.001095678419236506
comorbidity,0.001095678419236506
consider,0.001095678419236506
involve,0.001095678419236506
ktr,0.001095678419236506
lead,0.001095678419236506
legal,0.001095678419236506
longer,0.001095678419236506
maintenance,0.001095678419236506
mainly,0.001095678419236506
match,0.001095678419236506
contraindication,0.001095678419236506
creatininuria,0.001095678419236506
cyclosporine,0.001095678419236506
degree,0.001095678419236506
decided,0.001095678419236506
development,0.001095678419236506
indicating,0.001095678419236506
independently,0.001095678419236506
inferiority,0.001095678419236506
initiated,0.001095678419236506
inhibition,0.001095678419236506
interferon,0.001095678419236506
interventional,0.001095678419236506
survey,0.001095678419236506
details,0.001095678419236506
despite,0.001095678419236506
diffuse,0.001095678419236506
diagnostic,0.001095678419236506
distribution,0.001095678419236506
easily,0.001095678419236506
drop,0.001095678419236506
eltrombopag,0.001095678419236506
growth,0.001095678419236506
haut,0.001095678419236506
hormonal,0.001095678419236506
improve,0.001095678419236506
immunosuppressants,0.001095678419236506
immunosuppressant,0.001095678419236506
immunomodulatory,0.001095678419236506
tarte,0.001095678419236506
eq5d,0.001095678419236506
enzymes,0.001095678419236506
estimation,0.001095678419236506
equivalent,0.001095678419236506
equal,0.001095678419236506
excluded,0.001095678419236506
explored,0.001095678419236506
experienced,0.001095678419236506
experience,0.001095678419236506
thymocyte,0.001095678419236506
threshold,0.001095678419236506
fever,0.001095678419236506
fluid,0.001095678419236506
functional,0.001095678419236506
fresh,0.001095678419236506
frequently,0.001095678419236506
glomerular,0.001095678419236506
gold,0.001095678419236506
2011,0.001095678419236506
250,0.001095678419236506
42,0.001095678419236506
5l,0.001095678419236506
61,0.001095678419236506
acr,0.001095678419236506
question,0.001095678419236506
quantification,0.001095678419236506
reaches,0.001095678419236506
records,0.001095678419236506
requirements,0.001095678419236506
responding,0.001095678419236506
retinopathy,0.001095678419236506
room,0.001095678419236506
rodnan,0.001095678419236506
sequentially,0.001095678419236506
santé,0.0009698644169170862
sledai,0.0009698644169170862
regression,0.0009698644169170862
ref,0.0009698644169170862
recommendation,0.0009698644169170862
virological,0.0009698644169170862
account,0.0009698644169170862
activation,0.0009698644169170862
achieved,0.0009698644169170862
aa,0.0009698644169170862
future,0.0009698644169170862
49,0.0009698644169170862
65,0.0009698644169170862
global,0.0009698644169170862
gr,0.0009698644169170862
estimate,0.0009698644169170862
estimated,0.0009698644169170862
erythrocyte,0.0009698644169170862
formula,0.0009698644169170862
fludarabine,0.0009698644169170862
functions,0.0009698644169170862
hypothesis,0.0009698644169170862
hematological,0.0009698644169170862
immunological,0.0009698644169170862
evaluate,0.0009698644169170862
damage,0.0009698644169170862
criterion,0.0009698644169170862
cure,0.0009698644169170862
correlated,0.0009698644169170862
like,0.0009698644169170862
taking,0.0009698644169170862
infarct,0.0009698644169170862
institut,0.0009698644169170862
deterioration,0.0009698644169170862
effective,0.0009698644169170862
elderly,0.0009698644169170862
tolerated,0.0009698644169170862
mechanical,0.0009698644169170862
context,0.0009698644169170862
malignant,0.0009698644169170862
talimogene,0.0009698644169170862
cytokines,0.0009698644169170862
define,0.0009698644169170862
depression,0.0009698644169170862
programme,0.0009698644169170862
allograft,0.0009698644169170862
aged,0.0009698644169170862
silent,0.0009698644169170862
selena,0.0009698644169170862
phenotypic,0.0009698644169170862
ventilation,0.0009698644169170862
usually,0.0009698644169170862
bleeding,0.0009698644169170862
meeting,0.0009698644169170862
candidate,0.0009698644169170862
bmt,0.0009698644169170862
note,0.0009698644169170862
needs,0.0009698644169170862
moderate,0.0009698644169170862
models,0.0009698644169170862
mismatch,0.0009698644169170862
cerebral,0.0009698644169170862
mmol,0.0009698644169170862
combined,0.0009698644169170862
class,0.0009698644169170862
computed,0.0009698644169170862
consecutive,0.0009698644169170862
judgment,0.0009698644169170862
laherparepvec,0.0009698644169170862
answer,0.0009698644169170862
pan,0.0009698644169170862
pathology,0.0009698644169170862
person,0.0009698644169170862
beginning,0.0009698644169170862
biomarkers,0.0009698644169170862
binding,0.0009698644169170862
stroke,0.0009698644169170862
isatuximab,0.0008634901936471263
antibiotics,0.0008634901936471263
2016,0.0008634901936471263
neurological,0.0008634901936471263
biopsies,0.0008634901936471263
intensive,0.0008634901936471263
low,0.0008634901936471263
limited,0.0008634901936471263
historical,0.0008634901936471263
hospitalizations,0.0008634901936471263
thrombosis,0.0008634901936471263
family,0.0008634901936471263
2014,0.0008634901936471263
able,0.0008634901936471263
therapies,0.0008634901936471263
therapeutic,0.0008634901936471263
haze,0.0008634901936471263
effect,0.0008634901936471263
transfusion,0.0008634901936471263
engraftment,0.0008634901936471263
terms,0.0008634901936471263
surgery,0.0008634901936471263
costs,0.0008634901936471263
cov2,0.0008634901936471263
proportion,0.0008634901936471263
performance,0.0008634901936471263
start,0.0008634901936471263
overload,0.0008634901936471263
percentage,0.0008634901936471263
calculated,0.0008634901936471263
presented,0.0008634901936471263
cause,0.0008634901936471263
measure,0.0008634901936471263
classic,0.0008634901936471263
chamber,0.0008634901936471263
iron,0.0008634901936471263
composite,0.0008634901936471263
mixed,0.0008634901936471263
neutrophils,0.0008634901936471263
plan,0.0008634901936471263
opinion,0.0008634901936471263
edema,0.0007713446501535326
vitreous,0.0007713446501535326
includes,0.0007713446501535326
rates,0.0007713446501535326
interval,0.0007713446501535326
unrelated,0.0007713446501535326
cardiac,0.0007713446501535326
steroids,0.0007713446501535326
step,0.0007713446501535326
validated,0.0007713446501535326
overall,0.0007713446501535326
anterior,0.0007713446501535326
prca,0.0007713446501535326
adapted,0.0007713446501535326
vessel,0.0007713446501535326
